Samba Technologies

Samba BioLogics is a preclinical-stage biotechnology company focused on developing breakthrough agonist biologics for regenerative medicine. The company's lead programs, Cell-Kro and VasaPlex, are designed to preserve tissue and improve repair after ischemic injuries, such as heart attacks. Cell-Kro is a combination therapy that primes reparative cells for successful engraftment and survival, while VasaPlex is a cardioprotective biologic designed to increase vascular integrity. Samba BioLogics aims to harness scientific discovery to heal tissues and organs by promoting the body's innate preservation and repair mechanisms.